Venture firm Mindset Partners has hired Jules Miller, an IBM veteran who headed up a blockchain-focused accelerator.
Month: July 2020
Genome Medical grows series B to $37m
The genetic testing services provider has added a Samsung-led second close to a $23m first tranche that included a range of corporate investors.
Intel hits its annual investment mark
Well, that is one way to hit your annual investment targets. US-listed chip and data provider Intel on Friday said it would invest $253.5m for a 0.39% stake in India-based phone operator Jio Platforms, joining a roster of high-profile investors to have backed the spin-off from Reliance Industries in the past few weeks. Intel joins… Continue reading Intel hits its annual investment mark
Jüsto dices up $12m
Jüsto has lured the return of Femsa Ventures in a round that will expand its grocery e-commerce offering in Mexico and Colombia.
Novo to open Asian investment activities
Amit Kakar will supervise a Singapore office that will spearhead the pharmaceutical company’s corporate venturing investments across Asia.
Carbon Clean Solutions catches $22m
Equinor Ventures participated in a series B that represents the CO2 separation technology provider’s second funding round this year.
CampusLogic bets on RaiseMe acquisition
The student aid service has been bought by CampusLogic after raising more than $31m from investors including Salesforce Ventures.
Corporate venturing deal net: 29 June-3 July 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Citryll succeeds in series A close
ModiQuest’s NET-targeted antibody spinoff closed a $20.9m round that also featured BrightGene, both having contributed to the first close last year.
This time really seems to be different
“The four most expensive words in investing are: ‘This time it’s different’,” according to legendary investor and mutual fund pioneer Sir John Templeton.
Velodyne visualises reverse merger
A year after reportedly hiring banks for an IPO, multi-corporate-backed Velodyne has instead chosen a reverse merger to list on the New York Stock Exchange.
Nasdaq receives Accolade in $220m IPO
Comcast, McKesson, Humana and Independence Health all scored exits as the health benefits services provider floated in an upscaled offering.
Caffeine rushes to $113m series D
The livestreaming broadcaster was valued at more than $600m in a round co-led by investors including Cox Enterprises and Fox Corporation.
CF PharmTech sees its way to $50m
Drug developer CF PharmTech has raised $50m in an SAIC-backed series F round just six months after closing $90m in series E funding.